Condition
Sciatica Acute
Total Trials
4
Recruiting
2
Active
3
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
50%
2 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (2)
P 3 (1)
P 4 (1)
Trial Status
Recruiting2
Active Not Recruiting1
Completed1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT07397117Not ApplicableRecruitingPrimary
Comparing Ultrasound-Guided Transgluteal Nerve Block to Standard Care
NCT07161323Not ApplicableRecruiting
SNAG and SNME in Non-Specific Sciatic Pain
NCT06157177Phase 4Active Not RecruitingPrimary
Efficacy of M640 in Acute Lumbosacral Musculoskeletal Conditions.
NCT05626140Phase 3CompletedPrimary
COMPARISON OF EFFICACY OF DIFFERENT DRUG COMBINATIONS IN ACUTE SCIATICA
Showing all 4 trials